<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365591">
  <stage>Registered</stage>
  <submitdate>20/01/2014</submitdate>
  <approvaldate>5/02/2014</approvaldate>
  <actrnumber>ACTRN12614000145606</actrnumber>
  <trial_identification>
    <studytitle>Comparison of frusemide alone and frusemide and Indapamide on sodium excretion and balance in fluid overloaded Intensive Care Unit (ICU) patients</studytitle>
    <scientifictitle>Comparison of frusemide alone and frusemide and Indapamide on sodium excretion and balance in fluid overloaded Intensive Care Unit (ICU) patients.</scientifictitle>
    <utrn>U1111-1151-9785</utrn>
    <trialacronym />
    <secondaryid>NIL</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Sodium excretion and balance in fluid overloaded patients</healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Other renal and urogenital disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Effects of orally administered as once only dose of  frusemide (0.5-1mg/kg) with indapamide (5mg) on 24 hours urinary sodium excretion in ICU patients with fluid overload </interventions>
    <comparator>Effects of orally administered as once only dose of frusemide (0.5-1mg/kg)  on 24 hours urinary sodium excretion in ICU patients with fluid overload </comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Compare the urinary sodium excretion in ICU patients with fluid overload treated with frusemide and frusemide with Indapamide.

Data for sodium and fluid intake for 24 hours would be collected for assessment by measuring sodium levels in bloods and urine.</outcome>
      <timepoint>Outcome will be assessed at 24hrs after Frusemide or Frusemide with Indapamide administration.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Bloods and urine samples will be sent for electrolytes and renal function to compare the fluid balance, urinary potassium, magnesium excretion and creatinine clearance in ICU patients with fluid overload treated with frusemide and frusemide with Indapamide.</outcome>
      <timepoint>Outcome will be assessed at 24hrs after Frusemide or Frusemide with Indapamide administration.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients with fluid overload and indwelling urine catheter </inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1 Patients on renal replacement therapy
2 Patients with other drains present (for e.g. surgical    drains, chest drain)
3 Child C liver disease
4 Patients not expected to survive for next 24 hours or those not for active treatment  based on the treating consultant opinion
5 Patients on regular diuretics
6 Patients with chronic renal disease with baseline Creatinine &gt; 180 umol/L
7 Sulphonamide allergy
8 Lactose intolerant 
9 Suspected or confirmed pregnancy
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence>Using computer generated random codes </sequence>
    <masking>Open (masking not used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>Using a 2 tailed significance, with alpha of 0.05 and a power of 80% we estimate 33 patients per group are required to show a statistical difference between the groups. To allow for contingency we aim to include 40 patients in each group.</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>4/11/2013</anticipatedstartdate>
    <actualstartdate>4/11/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>SA</recruitmentstate>
    <hospital>Flinders Medical Centre - Bedford Park</hospital>
    <postcode>5042 - Bedford Park</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Shailesh Bihari</primarysponsorname>
    <primarysponsoraddress>Shailesh Bihari, Intensive and Critical Care Unit, Flinders Medical Centre, Flinders Drive, Bedford Park, South Australia 5042</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Not funded</fundingname>
      <fundingaddress>Not funded</fundingaddress>
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>A prospective randomized clinical trial to compare the urinary sodium excretion in ICU patients with fluid overload treated with frusemide alone when compared with frusemide and Indapamide</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname> Southern Adelaide Clinical Human Research Ethics Committee (SAC HREC)</ethicname>
      <ethicaddress>The Flats, G5 - Rooms 3 and 4
Flinders Drive 
Flinders Medical Centre 
Bedford Park SA 5042
</ethicaddress>
      <ethicapprovaldate>26/08/2013</ethicapprovaldate>
      <hrec>191.13</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Shailesh Bihari</name>
      <address>Intensive and Critical Care Unit
Flinders Medical Centre, Flinders Drive, Bedford Park, South Australia-5042</address>
      <phone>+61 8 8204 7288</phone>
      <fax />
      <email>biharishailesh@gmail.com</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Shailesh Bihari</name>
      <address>Intensive and Critical Care Unit
Flinders Medical Centre, Flinders Drive, Bedford Park, South Australia-5042</address>
      <phone>+61 8 8204 7288</phone>
      <fax />
      <email>biharishailesh@gmail.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Shailesh Bihari</name>
      <address>Intensive and Critical Care Unit
Flinders Medical Centre, Flinders Drive, Bedford Park, South Australia-5042</address>
      <phone>+61 8 8204 7288</phone>
      <fax />
      <email>biharishailesh@gmail.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Yograjsinh Sagar</name>
      <address>Pharmacy Dept.
Flinders Medical Centre, Flinders Drive, Bedford Park, South Australia-5042</address>
      <phone>+61 8 8204 6807</phone>
      <fax />
      <email>yogi.sagar@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>